Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-11-27Clinical Trial Update: Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic Syndrome [Phase 4]
Phase 4 trial evaluating safety and efficacy of aripiprazole and ziprasidone in schizophrenia patients with metabolic syndrome; study comple…
-
FDA approval · 2012-11-27FDA Approved: RISPERIDONE — Supplemental Application (Chartwell RX, LLC)
FDA approved Chartwell RX, LLC's generic risperidone through an ANDA, authorizing the generic product for the same indications as the brand.
-
CLINICAL_TRIALS trial_result · 2012-11-19Clinical Trial Update: Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone [NA]
A completed clinical trial evaluated diabetes risk factors in people with schizophrenia or bipolar disorder after switching to ziprasidone; …
-
FDA approval · 2012-11-08FDA Approved: SAPHRIS — Supplemental Application (Allergan, Inc.)
FDA approved Allergan's supplemental application for SAPHRIS (asenapine), resulting in labeling changes for the antipsychotic.
-
CLINICAL_TRIALS trial_result · 2012-11-08Clinical Trial Update: The Effect of JNJ-39393406 on Event Related Potentials in Stable Schizophrenic Patients [Phase 1]
A Phase 1 trial assessing the effect of JNJ-39393406 on event-related potentials in stable schizophrenia patients was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-11-05Clinical Trial Update: A Study to Observe Real-life Allocation of Antipsychotics in Acute Inpatient Management of Schizophrenia
AstraZeneca-sponsored observational study completed, examining how antipsychotics are allocated in real-world practice for acute inpatient m…
-
CLINICAL_TRIALS research · 2012-11-05Clinical Trial Update: A Study to Compare Two Different Brain Imaging Techniques in Healthy Volunteers and in Schizophrenic Patients
A completed clinical trial comparing two brain imaging techniques in healthy volunteers and in people with schizophrenia.
-
FDA approval · 2012-10-29FDA Approved: RISPERIDONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for risperidone by Sun Pharmaceutical Industries, Inc. (ANDA 078474).
-
CLINICAL_TRIALS research · 2012-10-25Clinical Trial Update: N-methyl-D-aspartic Acid (NMDA) and Cognitive Remediation in Schizophrenia [Phase 2]
An update on a Phase 2 trial investigating N-methyl-D-aspartic acid (NMDA) with cognitive remediation for schizophrenia and schizoaffective …
-
CLINICAL_TRIALS trial_result · 2012-10-24Clinical Trial Update: Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder [Phase 4]
Phase 4 clinical trial comparing long-acting risperidone to oral risperidone in schizophrenia patients with alcohol use disorder has complet…
-
CLINICAL_TRIALS withdrawal · 2012-10-24Clinical Trial Update: Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty Acids [Phase 3]
A Phase 3 clinical trial evaluating adjunctive supplementation with vitamins E and C plus omega-3 fatty acids for schizophrenia was terminat…
-
CLINICAL_TRIALS trial_result · 2012-10-23Clinical Trial Update: Different Safety Profile of Risperidone and Paliperidone Extended-release [Phase 4]
Phase 4 trial comparing safety profiles of risperidone and paliperidone extended-release in schizophrenia; results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-10-22Clinical Trial Update: A Trial to Explore the Tolerability, Safety and Efficacy of Paliperidone Extended Release in Patients With Schizophrenia [Phase 3]
A Phase 3 trial evaluated the tolerability, safety and efficacy of Paliperidone Extended Release in patients with schizophrenia. The results…
-
FDA approval · 2012-10-22FDA Approved: RISPERIDONE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for risperidone from Aurobindo Pharma Limited (generic risperidone).
-
FDA approval · 2012-10-18FDA Approved: RISPERIDONE — Supplemental Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals' supplemental application for risperidone under an ANDA, confirming approval of a change associated…
-
CLINICAL_TRIALS trial_result · 2012-10-10Clinical Trial Update: First-in-Human Study to Evaluate AMG 579 in Healthy Subjects and Patients With Stable Schizophrenia [Phase 1]
First-in-human Phase 1 study of AMG 579 in healthy subjects and individuals with stable schizophrenia; the trial status is terminated.
-
EMA guidance · 2012-10-09European Medicines Agency releases guideline on medicinal products for the treatment of schizophrenia
EMA releases a guideline outlining considerations for medicinal products intended to treat schizophrenia.
-
CLINICAL_TRIALS trial_result · 2012-10-08Clinical Trial Update: An Open Label Multicentre Study to Determine the Dose Distribution of Paliperidone ER in Patients With Schizophrenia [Phase 3]
This clinical trial update reports on a Phase 3 open-label multicenter study evaluating the dose distribution of Paliperidone ER in patients…
-
CLINICAL_TRIALS trial_result · 2012-10-05Clinical Trial Update: Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder [Phase 3]
Phase 3 trial results for quetiapine fumarate (SEROQUEL) in adolescent patients with schizophrenia and Bipolar I Disorder. The study has com…
-
CLINICAL_TRIALS trial_result · 2012-09-28Clinical Trial Update: Attention Shaping Procedures for Improving Psychosocial Skills Among Adults With Schizophrenia [NA]
A clinical trial update indicates that a study on attention shaping procedures to improve psychosocial skills in adults with schizophrenia h…
-
CLINICAL_TRIALS trial_result · 2012-09-25Clinical Trial Update: A Study in Schizophrenia Patients [Phase 2]
Phase 2 schizophrenia trial sponsored by Eli Lilly has completed.
-
CLINICAL_TRIALS research · 2012-09-19Clinical Trial Update: Decision Aid to Facilitate Shared Decision Making During Treatment in Schizophrenia [NA]
This clinical trial update reports on a decision aid designed to facilitate shared decision making during treatment for schizophrenia and sc…
-
CLINICAL_TRIALS trial_result · 2012-09-18Clinical Trial Update: A Positron Emission Tomography Study of SLV354 in Healthy Subjects and Subjects With Schizophrenia [Phase 1]
Phase 1 PET imaging study of SLV354 in healthy subjects and individuals with schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-18Clinical Trial Update: A Study of the Effects of Sarcosine on Symptoms and Brain Glycine Levels in People With Schizophrenia [NA]
The document reports a completed clinical trial examining the effects of sarcosine on symptoms and brain glycine levels in individuals with …
-
CLINICAL_TRIALS research · 2012-09-18Clinical Trial Update: The Consta Club: A Demonstration Project for Setting up a Consta Club in a Community Mental Health Center [NA]
A demonstration project to set up a Consta Club in a community mental health center. The study status is completed.